Xintela AB(SE:XINT)
kr 0.140.00 (0.00%)
SE:XINT
Xintela AB stock drug pipeline
kr 0.14
At close:0.00 (0.00%)
Want to see SE:XINT full AI Analyst Report?
Xintela AB (XINT) Drug Pipeline
0 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Vehicle, Xstem-Vlu | Venous Leg Ulcer | phase1AndPhase2 | Recruiting | A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers | Sep 06, 2022 | ― |
| Xstem-Oa | Osteoarthritis, Knee | phase1AndPhase2 | Completed | A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis | Apr 04, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Vehicle, Xstem-Vlu | phase1AndPhase2 | Venous Leg Ulcer | Recruiting | A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers | Sep 06, 2022 | ― |
| Xstem-Oa | phase1AndPhase2 | Osteoarthritis, Knee | Completed | A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis | Apr 04, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Xintela AB (SE:XINT) have in its pipeline
Xintela AB SE:XINT is currently developing the following drugs: Vehicle, Xstem-Vlu, Xstem-Oa. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
